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INVITED COMMENTARY
K. Craig Kent, MD New York, NY
In the current issue of Journal of Vascular Surgery, Wanhainen
et al address the controversial but timely question of whether
women should be screened for abdominal aortic aneurysms
(AAAs). The publication of this manuscript coincides temporally
with a landmark accomplishment in the United States, as legisla-
tion mandating reimbursement for AAA screening for 65-year-
old ever-smoking men has now passed the Senate and House of
Representatives and, with luck, will soon be signed into law.
Although, there now appears to be relatively uniform consensus
that AAA screening is useful in men, for women, the controversy
continues on.
It has long been understood that AAAs are less prevalent in
women than in men, and there is little doubt that disease preva-
lence is a critical contributor to the cost-effectiveness of screening.
Moreover, the Chichester Aneurysm Study, a small but random-
ized study, did not demonstrate an advantage of AAA screening in
women. But as clearly established by the authors of this article,
prevalence is not the only factor of importance when evaluating the
cost-effectiveness of aneurysm screening.
When it comes to aneurysms, there is little dispute that women
behave differently than men. Yes, prevalence is less in women;
however, aneurysms in women rupture at an increased rate and at
a smaller size. Paraphrased, fewer aneurysms are found by screen-
ing women, but the ones that are found are more dangerous.
Although the ratio of prevalence is fairly well established at approx-
imately 5:1, men vs women, the increased propensity for aneurysm
rupture in women is less well documented. The authors, in their
base case analysis, use a ratio of 3:1, women vs men, based upon
data from the United Kingdom Small Aneurysm Study.
Wanhainen et al also point out that in addition to prevalence
and rupture rate, multiple other factors are essential to this analysis,
including patient longevity, which appears to be less in women
with AAA than in men, and death after rupture, which is greater in
women than in men. The outcome of all of these factors, when
introduced into a detailed Markov model, is that screening for
AAA in women is extremely cost-effective. Moreover, in sensitivity
analyses, the cost-effectiveness of screening remains robust despite
a number of variations in assumptions, including prevalence.
Cost-effective analyses are only as good as the data that are
introduced into the model, and as Wanhainen et al clearly state,
there are a paucity of data regarding the natural history of aneu-
rysms in women. However, until more data become available, it
seems prudent to be inclusive of women in screening programs. In
light of this analysis, the recent opinion rendered by the United
States Preventative Service Task Force, that “screening in women is
harmful,” seems unwarranted.
One fact that we can all agree on is that aneurysms behave
differently in women than in men. The responsibility is ours to
better understand these differences. Until more data becomes
available it seems best to be inclusive rather than exclusive and
include high risk women in our screening programs.
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